News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–4
Matches
4
Sources here
3
Companies here
1
Search results Stored financial headlines

Active search

4 matching headlines

Ticker or company: PPGNMain company stories
Clear
Latest

finance.yahoo.com Deals and strategy

Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal

Samsung Biologics is set to acquire PolyPeptide Group through an all-cash public tender offer valued at SFr1.46bn ($1.81bn). The proposed offer is set at SFr44.31 per share for 100% of PolyPeptide's fully diluted share capital, excluding treasury shares. Completion of the deal is anticipated towards the end of this year, contingent on meeting a minimum acceptance threshold of …

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approximately CHF 1.46 billion. Strong transaction support, with a unanimous recommendation from …

PPGN main company
Sharemaestro market context Trend signal active 52 weeks +56.4% PPGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context